| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.01 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.02 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.4 | 0.02 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |